698 research outputs found

    Orchestrating home

    Get PDF
    The private space of the home is an important site of health care in most industrialised countries, and rehabilitation following intensive in-hospital treatment largely takes place in domestic settings. Home in this context is implicitly understood by individuals affected by illness (people with illness, family members, friends, carers), health care providers, and policy makers as an a priori entity that naturally provides continuity and stability. This takes for granted that family carers will maintain both therapeutic activities and the sense of ‘being at home’ – and all of the accompanying emotional dimensions – within the home environment. Drawing on ethnographic research with relatively young spousal carers in Victoria, Australia, we explore how the reconstruction of home as a site for post-stroke recovery changed the experiences and meanings given to the idea of home. Home as a therapeutic place depended on constant orchestrating work that reconfigured the physical, symbolic, and practical elements of home. This was not a straightforward or singular process, as tensions arose in trying to integrate the new, post-stroke therapeutic landscape and pre-stroke conceptualisations and lived realities of home life

    Flow and Transport in Hierarchically Fractured Systems

    Get PDF

    A Study on the Arts Curriculum in Elementary Education in Australia: Focusing on Music Learning Area

    Get PDF

    THE REGULATORY LANDSCAPE OF THE RET GENE IN HIRSCHSPRUNG DISEASE

    Get PDF
    Hirschsprung disease (HSCR), or congenital aganglionosis, is characterized by a contiguous lack of enteric neurons in variable segments of the gut. Both coding and non-coding mutations in the receptor tyrosine kinase RET are the major genetic drivers of the disease, although all disease causing mutations in RET have not yet been identified. A prior Genome Wide Association Study (GWAS) using 220 HSCR trios identified 38 common single nucleotide polymorphisms (SNPs) that are significantly associated with the disease and are located in non-coding regions at the RET locus. Eight of these SNPs disrupt known RET transcription factor binding sites in the human neuroblastoma cell line, SK-N-SH, and are located within enhancer elements. Three of these eight SNPs show differential enhancer activity between the non-risk and disease associated (risk) alleles, or an allelic difference. I sought to determine how many of the remaining 30 SNPs displayed enhancer activity and allelic differences by using a dual in vitro luciferase reporter assay in SK-N-SH cells. My studies revealed that 28 SNPs had enhancer activity while seven of those displayed allelic differences. The SNPs that showed an allelic difference and affected enhancer activity potentially disrupt binding sites for PAX3, MZF1, ZNF263, and Myb/Mybl1. Therefore, the genetic risk of HSCR susceptibility at RET is conferred by allelic differences at at least 10 enhancer elements, demonstrating the high degree of intra-locus risk heterogeneity
    • …
    corecore